DRUGS MADE IN AMERICA ACQUISITION II CORP.: cashflow_operating
| Value | {"amount": -194299, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2024-08-23 – 2024-12-31 |
| Status | current |
| Entity | DRUGS MADE IN AMERICA ACQUISITION II CORP. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:07:31.882959+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b7c65900-20b0-49f2-93ab-d69b0465c929
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-26-044055Retrieved: 2026-08-19T19:07:31.882959+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0002040475/cashflow-operating/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b7c65900-20b0-49f2-93ab-d69b0465c929
History
- no predecessors — first report